Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor - Wikidata - wikimedia - TriplyDB

Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor

Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor

http://www.wikidata.org/entity/Q33677699

about

Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor

http://www.wikidata.org/entity/Q33677699

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Sorafenib and 2,3,5-triiodoben ...... embolization of a liver tumor

@ast

Sorafenib and 2,3,5-triiodoben ...... embolization of a liver tumor

@en

type

label

Sorafenib and 2,3,5-triiodoben ...... embolization of a liver tumor

@ast

Sorafenib and 2,3,5-triiodoben ...... embolization of a liver tumor

@en

prefLabel

Sorafenib and 2,3,5-triiodoben ...... embolization of a liver tumor

@ast

Sorafenib and 2,3,5-triiodoben ...... embolization of a liver tumor

@en

P1433

Q33677699-8F77351A-5FD4-4FFF-98A7-5D3F4DA80D46

P1476

Q33677699-4F495AA9-619E-404A-AA4F-4D0B37F8FC72

P2093

Q33677699-1C1FBE0D-5956-48C9-9FE4-63C91183EBFF

Q33677699-61AC50BF-933F-4002-8B1F-665AACE67BA7

Q33677699-740F87EA-EEB0-4A3A-97E2-E1C5F1B26251

Q33677699-9D778D97-1253-4A0A-92FA-020D6FEA5B7B

Q33677699-DA27CB0E-3794-4ECE-BE78-E294F3CC4BE8

Q33677699-DDC6E999-653A-44BF-B6C4-6E8154740050

Q33677699-F471EAFE-F286-4054-9E17-02FDB1B75F10

P2860

Q33677699-093348E7-9C69-43B9-AE45-D2F7F1DBC33F

Q33677699-0C32B00D-2DC7-4183-B4AA-6E0B5312F5B9

Q33677699-17665B6E-4E80-4D6D-9ABE-6C2BC40B9AA1

Q33677699-1D8A5C4B-7199-4B46-A8FF-8BC299621375

Q33677699-2520F4B9-4394-4E70-A35E-BFDCACBF1FE9

Q33677699-2BB26E01-6EEB-4A02-8784-2A57965F1634

Q33677699-359B0CE3-A753-4B31-87BF-271CF859F78F

Q33677699-3601D39B-0F6A-487B-8F53-A2D6CFDF3FAE

Q33677699-3711F518-3B9A-408B-8B36-F0BAA0A653F3

Q33677699-3746D270-5DFD-4490-8591-BE0436D1E68B

P2888

Q33677699-6CDF4B71-C66B-46CD-9D9E-7548149DDB55

P304

Q33677699-AB0828AC-BA71-4DA0-BF1E-B271467425A4

P31

Q33677699-3A4B87C7-F59D-4EA1-ABA1-EADC3CCBF0F7

P356

Q33677699-2F07D586-3027-4863-8649-D01AEAF049F9

P407

Q33677699-646690BE-FFBC-4EAD-8500-2DD4E6AA68BF

P433

Q33677699-A9A96563-921B-4975-8B52-E3D42CB4E5C5

P478

Q33677699-4DF923C5-AE4A-4B20-9D32-7FE5E46497AA

P577

Q33677699-DFC5EA66-1065-4B8D-9AC6-FD82366EB996

P6179

Q33677699-84DD24D8-C2A2-4F19-8763-B71BBBF6260D

P698

Q33677699-A3B42792-11FD-4504-BA96-7A31C7F4CB39

P921

Q33677699-03692A8F-7236-488E-9758-462F9A0DBDA2

P932

Q33677699-FB583BEB-7098-4463-B8DE-0DCA7508A1D2

P356

S41598-017-00709-4

P1433

Scientific Reports

P1476

Sorafenib and 2,3,5-triiodoben ...... embolization of a liver tumor

@en

P2093

Dae-Duk Kim

http://www.w3.org/2001/XMLSchema#string

Hye Rim Cho

http://www.w3.org/2001/XMLSchema#string

Hyo-Cheol Kim

http://www.w3.org/2001/XMLSchema#string

Hyun-Jong Cho

http://www.w3.org/2001/XMLSchema#string

Jin Woo Choi

http://www.w3.org/2001/XMLSchema#string

Jin Wook Chung

http://www.w3.org/2001/XMLSchema#string

Ju-Hwan Park

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

Sorafenib in advanced hepatocellular carcinoma

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads

MRI visible drug eluting magnetic microspheres for transcatheter intra-arterial delivery to liver tumors.

Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature.

Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

P2888

s41598-017-00709-4

P304

554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-00709-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084130818

http://www.w3.org/2001/XMLSchema#string

P698

28373713

http://www.w3.org/2001/XMLSchema#string

P921

P932

5429668

http://www.w3.org/2001/XMLSchema#string